Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone; ethinyloestradiol -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinyloestradiol; drospirenone -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone; ethinyloestradiol -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 75 microgram; ethinylestradiol, quantity: 40 microgram - tablet, sugar coated - excipient ingredients: povidone; lactose monohydrate; maize starch; montan wax; sucrose; magnesium stearate; macrogol 6000; calcium carbonate; purified talc - 1. oral contraception this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 125 microgram; ethinylestradiol, quantity: 50 microgram - tablet, sugar coated - excipient ingredients: calcium carbonate; magnesium stearate; purified talc; glycol montanate; lactose monohydrate; maize starch; macrogol 6000; sucrose; povidone - oral contraception

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet, sugar coated - excipient ingredients: purified talc; lactose monohydrate; macrogol 6000; sucrose; povidone; magnesium stearate; calcium carbonate; maize starch; glycol montanate - oral contraception

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

bayer new zealand limited - estradiol valerate 3mg; dienogest 2mg; estradiol valerate 2mg; dienogest 3mg; estradiol valerate 2mg; estradiol valerate 1mg - film coated tablet - active: estradiol valerate 3mg excipient: hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone pregelatinised maize starch purified talc titanium dioxide active: dienogest 2mg estradiol valerate 2mg excipient: hypromellose iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone pregelatinised maize starch purified talc titanium dioxide active: dienogest 3mg estradiol valerate 2mg excipient: hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone pregelatinised maize starch purified talc titanium dioxide active: estradiol valerate 1mg excipient: hypromellose iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone pregelatinised maize starch purified talc titanium dioxide hypromellose lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified talc titanium dioxide - oral contraception.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - yaz is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; lactose monohydrate; magnesium stearate; hypromellose; microcrystalline cellulose - indications: petibelle is indicated for use as an oral contraceptive.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose monohydrate; purified talc; titanium dioxide; magnesium stearate; hypromellose; microcrystalline cellulose - indications: yasmin is indicated for use as an oral contraceptive.